Calvin Stiller is Professor Emeritus in the Department of Medicine, Schulich School of Medicine and Dentistry at the University of Western Ontario. He is known nationally and internationally as an outstanding physician, scientist and entrepreneur who has championed innovation in health and biomedical research and its application for the improvement of health and the economy.
He is a pioneer in multi-organ transplantation and diabetes in Canada and led the Canadian multi-center study that established the importance of cyclosporine in transplantation that in turn, led to its worldwide use as first-line therapy to prevent acute rejection. He was the first to demonstrate the efficacy of immuno-suppression treatment in newly diagnosed Type 1 diabetes.

Having published over 250 scientific papers, Dr. Stiller’s achievements extend beyond discovery and translational research into the establishment of public and private funds that have enabled the successful transfer of knowledge and intellectual property into practical clinical application. He is the co-founder of the Canadian Medical Discoveries Fund Inc., the founding Chair of the Ontario Research and Development Challenge Fund and Chair and co-founder of the Ontario Institute for Cancer Research.

Dr. Stiller is the recipient of the Order of Canada, the Order of Ontario and in 2010 he was inducted into the Canadian Medical Hall of Fame. He is also the recipient of the 2010 Canada Gairdner Wightman Award. His contributions have greatly enriched and transformed the health and biomedical research landscape